Showing results (91-100 of 658) with videos related to
Sort By:
Pageof 66
Journal of the National Comprehensive Cancer Network : JNCCN|November 5, 2020
Proposed Additions to the NCCN Guidelines for Adult MedulloblastomaMarta Penas-Prado, Terri S Armstrong, Mark R GilbertJournal of Neuro-Oncology|January 31, 2014
Personal health records as portal to the electronic medical recordJennifer E Cahill, Mark R Gilbert, Terri S ArmstrongCancer Research|August 3, 2002
Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human gliomaMeena K Tanwar, Mark R Gilbert, Eric C HollandNeuro-Oncology|May 26, 2017
Blood-brain barrier pericyte importance in malignant gliomas: what we can learn from stroke and Alzheimer's diseaseSadhana Jackson, Ayman ElAli, Daniela Virgintino, et al.Neuro-Oncology|May 18, 2018
Immunotherapy in CNS cancers: the role of immune cell traffickingNivedita M Ratnam, Mark R Gilbert, Amber J GilesCancer|May 4, 2011
Clinical course of adult patients with ependymoma: results of the Adult Ependymoma Outcomes ProjectTerri S Armstrong, Elizabeth Vera-Bolanos, Mark R GilbertScientific Reports|November 9, 2019
Retinoid receptor turnover mediated by sumoylation, ubiquitination and the valosin-containing protein is disrupted in glioblastomaVirginia Rodriguez, Rolanda Bailey, Mioara Larion, et al.Current Oncology Reports|May 11, 2022
Diagnosis and Management of Stroke in Adults with Primary Brain TumorEdina Komlodi-Pasztor, Mark R Gilbert, Terri S ArmstrongNeuro-Oncology Advances|July 18, 2024
Pathways to hypermutation in high-grade gliomas: Mechanisms, syndromes, and opportunities for immunotherapyTuesday Haynes, Mark R Gilbert, Kevin Breen, et al.Neurosurgery|December 22, 2009
Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomasNobuhiro Hata, Naoki Shinojima, Joy Gumin, et al.Pageof 66